Group One Trading’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-202
Closed -$35K 5795
2018
Q3
$35K Buy
202
+94
+87% +$15.8K ﹤0.01% 4169
2018
Q2
$19K Buy
+108
New +$16.2K ﹤0.01% 4394
2018
Q1
Sell
-4,433
Closed -$472K 5611
2017
Q4
$373K Buy
4,433
+3,796
+596% +$316K ﹤0.01% 2492
2017
Q3
$59K Sell
637
-563
-47% -$43.7K ﹤0.01% 3548
2017
Q2
$96K Buy
+1,200
New +$66.5K ﹤0.01% 3138

Other funds holding LOXO

Group One Trading's LOXO Position: Q4 2018 in Review

Group One Trading sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 202 shares — an estimated $35K sold.

Group One Trading first reported a position in LOXO in Q2 2017 and held it in 5 quarters. The position peaked at $373K in Q4 2017. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • Group One Trading reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • Group One Trading sold 202 Loxo Oncology, Inc shares in Q4 2018, an estimated $35K.
  • Group One Trading first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 5 quarters.
  • Group One Trading's Loxo Oncology, Inc position peaked at $373K in Q4 2017.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.